Chronic obstructive pulmonary disease (COPD) is a prevalent and preventable disease associated with high morbidity and mortality. Severe and intermediate a 1 -antitrypsin (AAT) deficiency (serum levels ,11 and 11-20 mmol?L -1 , respectively) increase the risk of COPD in active smokers. However, little is known about the interaction of severe and intermediate AAT deficiency with modifiable COPD risk factors other than active smoking. In this study, a MEDLINE search was carried out for studies investigating the combined effect of environmental inhalants (occupation and passive smoking) and AAT deficiency in the lung. A total of 18 studies using established methods for the assessment of AAT deficiency were included in this review.Occupational exposures and passive smoking affected lung function decline or prevalence of respiratory symptoms in four out of five studies investigating subjects with severe AAT deficiency, and in eight out of 13 studies with a focus on intermediate AAT deficiency. While study designs mostly prohibited formal assessment of effect modification, an interaction between intermediate AAT deficiency and passive smoking was identified in two studies with children. Additional study limitations included small sample size, poor adjustment for confounding and misclassification of environmental exposure as well as AAT activity.In conclusion, population-based epidemiological studies with associated biobanks are needed to identify gene-environment interactions and population subgroups susceptible to a 1 -antitrypsin deficiency.KEYWORDS: a 1 -Antitrypsin, a 1 -antitrypsin deficiency, gene-environment interaction, occupational disorder, occupational exposure, passive smoking a 1 -ANTITRYPSIN DEFICIENCY AND COPD Aetiology and progression of chronic obstructive pulmonary disease (COPD) result from a complex interplay between genetic and environmental factors. More than 90% of COPD patients are current or ex-smokers. Thus, the environment is clearly of importance in disease development. However, the effect of cigarette smoking on pulmonary function is highly variable, suggesting a role for genetic susceptibility in the response to tobacco exposure [1,2]. Variations in the gene coding for a 1 -antitrypsin (AAT), the most abundant protease inhibitor circulating in the blood, is the only established genetic risk factor for COPD [3][4][5].